Xian International Medical Investment Co Ltd (SHE:000516) — Market Cap & Net Worth
Market Cap & Net Worth: Xian International Medical Investment Co Ltd (000516)
Xian International Medical Investment Co Ltd (SHE:000516) has a market capitalization of $1.32 Billion (CN¥9.02 Billion) as of June 18, 2026. Listed on the SHE stock exchange, this China-based company holds position #7894 globally and #1880 in its home market, demonstrating a 1.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Xian International Medical Investment Co Ltd's stock price CN¥4.03 by its total outstanding shares 2238896753 (2.24 Billion). Review Xian International Medical Investment Co (000516) financial obligations to assess the company's total debt and financial obligations.
Xian International Medical Investment Co Ltd Market Cap History: 2015 to 2026
Xian International Medical Investment Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $2.81 Billion to $1.32 Billion (-5.09% CAGR).
Xian International Medical Investment Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Xian International Medical Investment Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.34x
Xian International Medical Investment Co Ltd's market cap is 0.34 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $2.53 Billion | $3.93 Billion | $201.59 Million | 0.64x | 12.56x |
| 2017 | $1.58 Billion | $4.06 Billion | $194.54 Million | 0.39x | 8.10x |
| 2018 | $1.59 Billion | $2.04 Billion | $2.18 Billion | 0.78x | 0.73x |
| 2019 | $1.59 Billion | $990.95 Million | -$403.93 Million | 1.60x | N/A |
| 2020 | $4.12 Billion | $1.61 Billion | $45.36 Million | 2.56x | 90.79x |
| 2021 | $3.61 Billion | $2.92 Billion | -$822.17 Million | 1.24x | N/A |
| 2022 | $4.01 Billion | $2.71 Billion | -$1.18 Billion | 1.48x | N/A |
| 2023 | $2.66 Billion | $4.62 Billion | -$368.36 Million | 0.58x | N/A |
| 2024 | $1.73 Billion | $4.82 Billion | -$254.13 Million | 0.36x | N/A |
| 2025 | $1.41 Billion | $4.07 Billion | -$313.08 Million | 0.34x | N/A |
Competitor Companies of 000516 by Market Capitalization
Companies near Xian International Medical Investment Co Ltd in the global market cap rankings as of June 18, 2026.
Key companies related to Xian International Medical Investment Co Ltd by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #323 globally with a market cap of $80.16 Billion USD.
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #1002 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #1045 globally with a market cap of $25.71 Billion USD ( €21.99 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1331 globally with a market cap of $19.50 Billion USD ( RM77.67 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #323 | HCA Healthcare, Inc. | NYSE:HCA | $80.16 Billion | $388.16 |
| #1002 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1045 | Fresenius SE & Co. KGaA | XETRA:FRE | $25.71 Billion | €39.04 |
| #1331 | IHH Healthcare Bhd | KLSE:5225 | $19.50 Billion | RM8.79 |
Xian International Medical Investment Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Xian International Medical Investment Co Ltd's market cap moved from $2.81 Billion to $ 1.32 Billion, with a yearly change of -5.09%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.32 Billion | -6.06% |
| 2025 | CN¥1.41 Billion | -18.75% |
| 2024 | CN¥1.73 Billion | -34.90% |
| 2023 | CN¥2.66 Billion | -33.74% |
| 2022 | CN¥4.01 Billion | +10.97% |
| 2021 | CN¥3.61 Billion | -12.25% |
| 2020 | CN¥4.12 Billion | +159.18% |
| 2019 | CN¥1.59 Billion | -0.36% |
| 2018 | CN¥1.59 Billion | +1.23% |
| 2017 | CN¥1.58 Billion | -37.76% |
| 2016 | CN¥2.53 Billion | -9.93% |
| 2015 | CN¥2.81 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of Xian International Medical Investment Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.32 Billion USD |
| MoneyControl | $1.32 Billion USD |
| MarketWatch | $1.32 Billion USD |
| marketcap.company | $1.32 Billion USD |
| Reuters | $1.32 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Xian International Medical Investment Co Ltd
Xi'an International Medical Investment Company Limited provides healthcare services. It operates hospitals and medical centers. It also engages in insurance broking, tourism, and pharmaceutical production business. Xi'an International Medical Investment Company Limited was formerly known as Xi'an Kaiyuan Investment Group Co., Ltd. and changed its name to Xi'an International Medical Investment Com… Read more